Lutonix Drug Coated Balloon

Drug-coated Peripheral Transluminal Angioplasty Catheter

FDA Premarket Approval P170003 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Change in the frequency of endotoxin monitoring.

DeviceLutonix Drug Coated Balloon
Classification NameDrug-coated Peripheral Transluminal Angioplasty Catheter
Generic NameDrug-coated Peripheral Transluminal Angioplasty Catheter
ApplicantLUTONIX
Date Received2018-06-20
Decision Date2018-06-28
PMAP170003
SupplementS003
Product CodePRC
Docket NumberPremarket Approval (PMA) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Links U.S. Food & Drug Administration   Follow FDA En Español Search FDA   Home Food Drugs Medical Devices Radia
Advisory CommitteeCardiovascular
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product Yes
Applicant Address LUTONIX 9409 Science Center Drive new Hope, MN 55428

Supplemental Filings

Supplement NumberDateSupplement Type
P170003Original Filing
S025 2021-11-18 30-day Notice
S024
S023 2021-07-06 30-day Notice
S022
S021 2021-03-08 Real-time Process
S020
S019
S018 2020-04-13 30-day Notice
S017
S016 2020-01-21 Real-time Process
S015 2019-11-25 30-day Notice
S014 2019-10-03 Normal 180 Day Track No User Fee
S013
S012 2019-09-18 Special (immediate Track)
S011
S010
S009
S008 2019-04-25 Normal 180 Day Track No User Fee
S007
S006 2019-02-26 Real-time Process
S005
S004 2018-10-04 Real-time Process
S003 2018-06-20 30-day Notice
S002 2018-05-18 Special (immediate Track)
S001 2017-09-25 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.